| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2009 | US20090042975 Process For The Production Of Botanic Extracts |
| 02/12/2009 | US20090042973 Inhibitors of aspartyl protease |
| 02/12/2009 | US20090042972 Methods of using low-dose doxepin for the improvement of sleep |
| 02/12/2009 | US20090042971 Method of using low-dose doxepin for the improvement of sleep |
| 02/12/2009 | US20090042970 Methods and devices for desmopressin drug delivery |
| 02/12/2009 | US20090042969 Use of Specific Trifluoromethyl Ketones for Preventing and Treating Pancreatitis |
| 02/12/2009 | US20090042968 Therapeutic compositions for intranasal administration of ketorolac |
| 02/12/2009 | US20090042967 androgen receptor modulators; specific pyrrolidinone-functional benzonitrile compounds such as 2-Chloro-4-[4-hydroxy-5-methyl-2-oxopyrrolidin-1-yl]benzonitrile or 2-Chloro-4-[5-ethyl-3,3-difluoro-4-hydroxy-2-oxopyrrolidin-1-yl]benzonitrile |
| 02/12/2009 | US20090042966 anticarcinogenic agent; (2S)-3-[(5R)-1-Acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]-2-fluoropropan-1-amine for treating cancer |
| 02/12/2009 | US20090042965 Inhibitors for steroid response elements and related methods |
| 02/12/2009 | US20090042964 Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as beta-secretase inhibitors |
| 02/12/2009 | US20090042962 Therapeutic Agent for Keratoconjunctival Disorder |
| 02/12/2009 | US20090042961 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 02/12/2009 | US20090042960 1-Cycloalkyl-5-Iodotetrazoles |
| 02/12/2009 | US20090042959 Compounds having immunomodulator activity |
| 02/12/2009 | US20090042958 Composition and method for treating immune-mediated skin disorders |
| 02/12/2009 | US20090042956 Compositions and methods of using (r)-pramipexole |
| 02/12/2009 | US20090042955 Bicyclic sphingosine 1-phosphate analogs |
| 02/12/2009 | US20090042954 Trans-2-(4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)-4-pyrrolidineacetic acid; have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity |
| 02/12/2009 | US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES |
| 02/12/2009 | US20090042952 Sustained Release Composition for Oral Administration of Niacin |
| 02/12/2009 | US20090042951 Blood Pressure Reduction in Salt-Sensitive Hypertension |
| 02/12/2009 | US20090042950 Silicone to adjust release profile of active materials; topical applying to skins with penetration promoter and volatile solvent |
| 02/12/2009 | US20090042949 Indoles Useful in the Treatment of Inflammation |
| 02/12/2009 | US20090042948 Physiologically acceptable salts of 3--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 02/12/2009 | US20090042947 Pharmacologically active compounds containing sulfur |
| 02/12/2009 | US20090042946 Method and kit for controlling bleeding |
| 02/12/2009 | US20090042945 Benzo[d]isoxazol-3-yl-amine Compounds and Their Use as Vanilloid Receptor Ligands |
| 02/12/2009 | US20090042944 Potassium Channel Inhibitors |
| 02/12/2009 | US20090042943 Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors |
| 02/12/2009 | US20090042942 Muscarinic Receptor Antagonists |
| 02/12/2009 | US20090042941 Methods for Treating Disorders or Diseases Associated with Hyperlipidemia and Hypercholesterolemia While Minimizing Side Effects |
| 02/12/2009 | US20090042940 Methods and compositions using cholinesterase inhibitors |
| 02/12/2009 | US20090042939 Methods and Compositions Using Cholinesterase Inhibitors |
| 02/12/2009 | US20090042937 Nitroxides for use in treating or preventing amyloid-related diseases |
| 02/12/2009 | US20090042936 Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation |
| 02/12/2009 | US20090042935 Novel iv formulation of tipifarnib |
| 02/12/2009 | US20090042934 Sulfonyl-Quinoline Derivatives |
| 02/12/2009 | US20090042933 Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor |
| 02/12/2009 | US20090042932 Antimicrobial parenteral formulation |
| 02/12/2009 | US20090042931 Tricyclic Angiotensin II Agonists |
| 02/12/2009 | US20090042930 Pharmaceutical compositions containing clopidogrel bisulfate |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042928 Modulators of muscarinic receptors |
| 02/12/2009 | US20090042927 Salts, Prodrugs and Polymorphs of Fab I Inhibitors |
| 02/12/2009 | US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 02/12/2009 | US20090042925 Oxime substituted imidazoquinolines |
| 02/12/2009 | US20090042924 1,6-dimethyl-3-(pyridin-4-yl)-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one, used as anticarcinogenic or antitumor agents |
| 02/12/2009 | US20090042923 Method of Treating Tumors with Azaxanthones |
| 02/12/2009 | US20090042922 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042919 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 02/12/2009 | US20090042918 Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3 |
| 02/12/2009 | US20090042916 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 02/12/2009 | US20090042915 Preventive or therapeutic agent for herpesvirus-releated disease |
| 02/12/2009 | US20090042914 Delayed release formulations of 6-mercaptopurine |
| 02/12/2009 | US20090042913 Indolylalkylthienopyrimidylamines as modulators of the EP2 receptor |
| 02/12/2009 | US20090042912 DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE |
| 02/12/2009 | US20090042911 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/12/2009 | US20090042910 Quinoline derivatives for treating cancer |
| 02/12/2009 | US20090042909 Method of treating dermatological disorders |
| 02/12/2009 | US20090042908 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation |
| 02/12/2009 | US20090042907 Bicyclic aromatic sulfinyl derivatives |
| 02/12/2009 | US20090042906 Methods for treating cancers associated with constitutive egfr signaling |
| 02/12/2009 | US20090042905 Triazole derivatives as ligands of g-protein coupled receptors |
| 02/12/2009 | US20090042904 Substituted Phenly-Piperazine Compounds, Their Preparation And Use In Medicaments |
| 02/12/2009 | US20090042903 For treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; obesity; N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-C-phenyl-methanesulfonamide; C-(4-chloro-phenyl)-N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-methanesulfonamide |
| 02/12/2009 | US20090042902 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics |
| 02/12/2009 | US20090042901 Agent for prevention/therapy of disease caused by keratinocyte growth |
| 02/12/2009 | US20090042900 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/12/2009 | US20090042899 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 02/12/2009 | US20090042898 Use of compounds active on the sigma receptor for the treatment of mecanical allodynia |
| 02/12/2009 | US20090042897 Chemical Compounds |
| 02/12/2009 | US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | US20090042895 Antidepressant Piperidine Derivatives of Heterocycle-Fused Benzodioxans |
| 02/12/2009 | US20090042894 Novel species of acrocarpospora, a method of preparing iodinin, and the uses of iodinin |
| 02/12/2009 | US20090042893 Kinase inhibitors, compositions comprising them, and methods of their use |
| 02/12/2009 | US20090042892 Cetp Inhibitors |
| 02/12/2009 | US20090042891 6-(3-Fluorophenyl)-5-pyridin-4-ylpyrazin-2-amine, used in the treatment of asthma, chronic obstructive pulmonary disorder, fibrosis, emphysema, allergies, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, inflammatory bowel disease or autoimmune diseases |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | US20090042889 can be used to obtain a constant concentration of the active principle in the blood, thereby enabling the demethylating effect of the hydralazine without producing the hypotensive action thereof, such that the inventive composition can be used in cancer therapy |
| 02/12/2009 | US20090042888 Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 02/12/2009 | US20090042887 Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory Agents |
| 02/12/2009 | US20090042886 Benzamide Inhibitors of the P2X7 Receptor |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042883 Antitumor agent |
| 02/12/2009 | US20090042882 Substituted acetamides as modulators of the ep2 receptor |
| 02/12/2009 | US20090042881 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/12/2009 | US20090042880 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives |
| 02/12/2009 | US20090042879 Phthalazinone derivatives and pharmaceutical compositions comprising the same |
| 02/12/2009 | US20090042878 Thienopyrimidylamines as modulators of the ep2 receptor |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042876 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors |
| 02/12/2009 | US20090042875 Substituted heterocyclic compounds and uses thereof |
| 02/12/2009 | US20090042874 Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042872 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same |
| 02/12/2009 | US20090042871 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; N-{2-[10-(8-Allyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenothiazine-3-yl]-phenyl}-acetamide |
| 02/12/2009 | US20090042869 SIGNAL-DEPENDENT SPLICING OF TISSUE FACTOR PRE-mRNA IN PLATELET CELLS |